Antiviral activity against HIV-1 3B infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 4 days by MTT assay
Antiviral activity against BVDV NADL ATCC VR-534 infected in MDBK cells assessed as protection against virus-induced cytopathic effect after 3 or 4 days by MTT assay
Antiviral activity against YFV 17-D vaccine (Stamaril Pasteur J07B01) infected in BHK21 cells assessed as protection against virus-induced cytopathic effect after 3 or 4 days by MTT assay
Antiviral activity against Reovirus 1 ATCC VR- 214 infected in BHK21 cells assessed as protection against virus-induced cytopathic effect after 3 or 4 days by MTT assay
Antiviral activity against Human poliovirus 1 strain Sabin 1 virus infected in african green monkey Vero-76 cells after 2 days by plaque reduction assay
Inhibition of BVDV RNA-dependent RNA polymerase pre-incubated for preincubated for 30 mins before GTP addition and measured after 120 mins by fluorescence based microplate reader assay
Inhibition of His tagged BVDV NS5B Cdelta24 RNA dependent RNA polymerase expressed in Escherichia coli Rosetta DE3 preincubated for 30 mins followed by addition of GTP measured after 120 mins by fluorescence analysis
Inhibition of His tagged BVDV NS5B Cdelta24 RNA dependent RNA polymerase K263A mutant expressed in Escherichia coli Rosetta DE3 preincubated for 30 mins followed by addition of GTP measured after 120 mins by fluorescence analysis
Inhibition of His tagged BVDV NS5B Cdelta24 RNA dependent RNA polymerase R295A mutant expressed in Escherichia coli Rosetta DE3 preincubated for 30 mins followed by addition of GTP measured after 120 mins by fluorescence analysis
Inhibition of His tagged BVDV NS5B Cdelta24 RNA dependent RNA polymerase Y674A mutant expressed in Escherichia coli Rosetta DE3 preincubated for 30 mins followed by addition of GTP measured after 120 mins by fluorescence analysis